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ABSTRACT
Benzene is one of the dangerous chemical substances which can cause some health disturbances.
Meta-analysis shows that people who are exposed to benzene have a leukemia risk of 1.4 times
more than the ones who are not. The employees who are exposed to benzene for a long time
have a probability to receive the toxic effect from benzene. This study was conducted to evaluate
the relationship between the intensity of benzene exposure and blood count of employees in the
oil and natural gas company in East Kalimantan. This research was conducted to 897 employees
with case control design. The control group consisted of 521 subjects, whereas the case group
consisted of 376 subjects. The subjects were 39.91±10.90 years old, with the working term
between 1 to 36 years. Data were obtained from routine medical check-up and health risk
assessment in 2007 – 2010. The independent variable namely benzene exposure and the dependent
variable namely result of blood count, were analyzed by using chi-square bivariat analysis.
Intensity of benzene exposure was measured as OVM (Organic Vapour Monitor) for external
dosage and SPMA (S-phenylmercapturic acid) for internal dosage. The intensity of benzene in
2007 was 1.07± 5.5 ppm (OVM) and average of SPMA was 11.54±5.28 ìg/g creatinine. The
intensity of benzene in 2009 was 4.15±13.6 ppm (OVM) and SPMA was 55.90±43.6 ìg/g
creatinine. The employees who were exposed to benzene had a risk of having a decrease of
either hemoglobin, erythrocyte, thrombocyte, or leukocyte 1.71 times (95% CI, 1.18–2.48)
compared with the control, although this reduction was still in the normal range (p= 0.004). In
conclusion, there was no relationship between the intensity of benzene exposure with the low
blood count of the employees.
ABSTRAK
Benzena adalah salah satu zat kimia berbahaya yang dapat menyebabkan beberapa gangguan
kesehatan. Meta analisis menunjukkan bahwa mereka yang terpapar benzene memiliki risiko
leukemia 1,4 kali dibandingkan dari mereka yang tidak terpapar benzene. Para karyawan yang
terkena benzena dalam waktu lama terdapat kemungkinan untuk terjadi efek toksik benzena.
Penelitian ini dilakukan pada 897 karyawan dengan desain case control. Kelompok kontrol terdiri
dari 521 subjek, sedangkan kelompok kasus terdiri dari 376 subjek. Subyek penelitian berumur
rata-rata 39,91 ± 10,90 tahun, dengan masa kerja antara 1 sampai 36 tahun. Pengumpulan data
diperoleh dari hasil check-up kesehatan rutin pada tahun 2007 - 2010. Variabel bebas adalah
paparan benzena dalam proses produksi, dan sebagai variabel terikat adalah hitung jenis darah,
yang dianalisis dengan menggunakan chi-square analisis bivariat. Intensitas benzena diukur dengan
menggunakan OVM (Organic Vapour Monitor, untuk benzene dosis eksternal) dan SPMA (S-
phenylmercapturic acid, untuk benzene dosis internal). Intensitas benzena rata-rata pada tahun
2007 adalah 1,07 ± 5,5 ppm (OVM) dan 11,54 ± 5,28 mg/g creatinine (SPMA). Intensitas
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benzena rata-rata pada tahun 2009 adalah 4,15±13,6 ppm (OVM) dan 55.90 ± 43,6 mg/g
creatinine (SPMA). Karyawan yang terkena benzena memiliki risiko untuk mengalami penurunan
dari salah satu komponen darah berikut yaitu hemoglobin, eritrosit, trombosit, atau lekosit 1,71
kali (95% CI: 1,18-2,48) dibandingkan kontrol, meskipun degradasi ini masih dalam kisaran
normal (p=0,004). Namun, tidak terdapat hubungan antara intensitas paparan benzene dengan
rendahnya hasil hitung jenis darah.
Keywords: benzene exposure - complete blood counts - oil and gas earth - mining - toxic effect
INTRODUCTION
Benzene is a chemical substance that is
widely used in industrial setting, ranging from
solvent to gasoline additives. Benzene is found
in the air out of the emissions from cigarette
smoke, motor vehicle exhaust, burning coal and
oil, and gasoline service stations.1 Although
benzene is widely used in industrial setting, it
has a toxic effect on the system of hematology,
reproduction and neurology. Workers who are
overexposed chronically can be inflicted to
anemia, leucopenia, and thrombocytopenia. The
peripheral blood morphology shows some
immature leukocyte such as band, meta-
mielocyte, mielocyte, or mieloblast.2
Moreover, benzene is a cancer-causing
carcinogen in workers exposed to high levels
of workplace air.3 Hundreds of leukemia cases
caused by benzene exposure have been reported
from some industries, such as shoes industry,
paint industry, and charcoal industry.4 The
occurrence of leukemia caused by benzene
needs a long time exposure. Adele et al.5
reported that it needed 50 years of benzene
chronic exposure with average 71.8 ppm/day
for someone to suffer leukemia. However,
epidemiological study shows that the leukemia
cases increase gradually among the workers who
work in high levels of benzene exposure.
Benzene is one of the best studied of the
known leukemia. However, the mechanism of
benzene-induced leukemia has not been well
postulated. Several hypotheses have been
proposed by some authors. It seems likely that
benzene has multiple effects consisting one or
more of the current hypotheses. The most
probable mechanism of benzene-induced
leukemia is through its phenolic metabolites
acting in concert to produce DNA damage. This
leads to mitotic recombination, chromosome
translocations, and aneuploidy. These genotoxic
events will, in turn, cause the activation of
protooncogenes, loss of heterozygosity, and
inactivation of tumor suppressor genes. If this
takes place in the bone marrow stem, a leukemic
clone with selective growth advantage can
arise. Epigenetic effects of benzene on the bone
marrow stroma can then assist in the
establishment of a leukemic clone.6,7
In the oil and natural gas mining, the
employees were exposed to benzene for a long
time. Therefore, the possibility to get
carcinogenicity effect from the benzene exposure
is high. Study concerning the impact of benzene
exposure is needed in order to develop an
effective program in early detection and
prevention of the negative impact of the
exposure. This study was conducted to evaluate
the relationship between the intensity of benzene
exposure with complete blood count of
employees in an oil and natural gas company in
East Kalimantan.
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MATERIALS AND METHODS
This was an observational study using case
control design. This study was conducted on
the employees of an oil and natural gas company
in East Kalimantan who were exposed to
benzene. Secondary data were obtained from
routine medical check-up and health risk
assessment. All the employees of the oil and
natural gas company were involved in this study
after applying the inclusion and exclusion
criteria. The inclusion criteria for the study was
any permanent and active employees who had
routine medical check-up data and complete
health risk assessment in the last 4 years. The
exclusion criteria was subjects who had
undergone acute bleeding, had been
hospitalized, had been diagnosed to have TBC,
typhoid fever, diabetes mellitus, stroke or non-
leukemic viciousness, when interviewed.
A total of 897 employees were selected in
this study. After being matched, they were
divided into two groups referred to as case
group (521 subjects) and control group (376
subjects). The case group was employees who
had been exposed to benzene in the workplace.
They worked as operator, production operator
and mechanic. The control group was
employees who were not exposed to benzene
in the workplace.
Dependent variables in this study were
blood count results (hemoglobin, leukocyte
number, platelet number, and erythrocyte
number). Independent variables were benzene
exposure intensity, benzene degree, self
protective equipment usage, and S-
phenylmercaptopuric acid (SPMA) degree.
Additional variables were age, gender, body
mass index, smoking habit, SGOT degree,
SGPT, and blood creatinine.
Benzene exposure in the workplace air was
classified as highly exposed and low exposed.
The measurement of benzene exposure was
conducted by using equipment SKC 575 Series
Passive Sampler which was known as OVM
(organic vapors measurement). Internal dosage
was calculated with urine S-phenylmercapturic
acid (SPMA). The SPMA degree was measured
by using GC-MS system, in the end of the shift,
after 8 hours of working. If the degree was e”
25 ìg/g creatinine, it was classified as high
exposure.8
Blood count including hemoglobin,
leukocyte number, platelet number, and
erythrocyte number, was counted by using
automatic counter. Disorder of blood element
was determined when the assessment result was
not in a normal range in the routine hematology
assessment. Bicytopenia was a degradation of
2 out of 4 parameters of complete blood count
such as leucopenia and anemia, leucopenia and
erythropenia, thrombocytopenia and anemia, or
combination of other degradations. It was
considered as abnormal if there were size, form,
and color which should not exist, such as band
form that was more than 10%, metamielocyte,
reactive limphocyte, or mieloblast.8-11
Data was analyzed with univariate and
bivariate analysis. Univariate analysis was
conducted to analyze data with interval/ratio
scale. Bivariate analysis used chi-square test
when both dependent and independent variable
were categorical data (nominal/ordinal). All
statistical analysis was considered significant
at p < 0.05.
Limitation in this research was that the
genotype variant check up MPO-463GG,
CYP2E1, GSTM1, and GSTT1 and NQO1-
465CT were not performed; the number of OVM
and SMPA were not sufficient; and benzene,
toluene, and xiline already existed naturally in
the form of compound from the source (well) to
the process place. Toluene and xilene effect
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were not analyzed in detail because there was
not any quantitative measurement for both gases.
This research protocol has been approved
by the Medical and Health Research Ethics
Committee, Faculty of Medicine, Universitas
Gadjah Mada, Yogyakarta.
RESULTS
Research subject was 39.91±10.90 years
old, with the youngest was 21 and the oldest
was 59 years old. The working term of the
employees varied between 1 to 36 years. The
average of BMI for 4 years was in the normal
category. Some of the smoking employees
(66.4%), consumed various number of
cigarettes, from 1 to 24 cigarettes per day. The
average of SGOT, SGPT, urea, creatinine, for
4 years was in the normal range.
There were 213 people who were exposed
to benzene, whereas 684 people were not
exposed to it. The number of bachelor
employees was only 9.9% from the total
employees. Majority of the workers were male
(94.5%) and the number of non-bachelor
employees was 87.9%. Working areas were
spread in several locations namely A, B, C, D,
E and F. The mining which had the most
employees was the B location, i.e. 185 people.
Although bicytopenia occurrence was
observed in the company, its occurrence was
the lowest (0.1-0.3%), while anemia occurrence
was the highest (20.6%), followed by
erythropenia (15.9%), thrombocytopenia
(4.3%), leucopenia (1.6%).
Benzene exposure can cause degradation
of one of the complete blood count such as
erythropenia, leucopenia, anemia, or thrombo-
cytopenia. This research analyzed the
degradation tendency of one of the peripheral
blood counts for 3 years in succession although
it was still in a normal range. It aimed to keep
being on guard against the degradation of
complete blood count up to under normal limit,
even bicytopenia or pancytopenia. Employees
who were exposed to benzene had a risk to have
a degradation of one of the complete blood count
for 3 years in succession, i.e. 1.71 times higher
(95% CI: 1.18 – 2.48) compared to those who
were not exposed to benzene (p < 0.05). A
bivariate analysis was performed to another
additional variable that could influence the
degradation of blood count. All results do not
have a significant relationship (p > 0.05).
Some complete blood count results showed
that there were abnormalities, such as
bicytopenia, anemia, thrombocytopenia,
leucopenia, and erythropenia. Bicytopenia
consisted of 3 kinds of abnormalities i.e.
leucopenia and thrombocytopenia, leucopenia
and erythropenia, or erythropenia and thrombo-
cytopenia. Leucopenia and thrombocytopenia
risk and erythropenia and thrombocytopenia risk
between the exposed and the unexposed group,
still could not be concluded due to the
insufficient number of sample in bicytopenia
case that was exposed to benzene. Leukopenia
and erythropenia risk for the group that was
exposed to benzene 1.61 (95% CI: 0.15-17.83)
times higher than those who were not exposed,
however it was not statistically different (p >
0.05).
Thrombocytopenia case for 1 year was
4.3%. Thrombocytopenia risk for 1 year in the
benzene exposed group was 0.36 (95% CI:
0.13-1.01) times lower than those who were
not exposed, however it was not statistically
different (p > 0.05). Leucopenia case for 1 year
was 1.5% from total employees. Leucopenia
risk in the benzene exposed group was 0.87
(95% CI: 0.24–3.16) times lower than those
who were not exposed, however it was not
statistically different (p > 0.05). Anemia case
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for 1 year was 20.7% and for 2 years in
succession was 1.1%. Anemia risk for 1 year
in the benzene exposed group was 1.20 (95%
CI: 0.24–3.16) times higher than those who were
not exposed, however it was not statistically
different (p > 0.05). Anemia risk for 2 years in
succession in the benzene exposed group was
2.16 (95% CI: 0.61–7.74) 2.16 (95% CI: 0.61
– 7.74) times higher than those who were not
exposed, however it was not statistically
different (p > 0.05). Erythropenia case for 1
year was 15.9% and for 2 years in succesion
was 0.5%. Erythropenia risk for 1 year in the
benzene exposed group was 1.15 (95% CI:
0.76-1.73) times higher than those who were
not exposed, however it was not statistically
different (p > 0.05). Erythropenia risk in benzene
exposed group was 2.15 (95% CI: 0.36– 12.96)
times than those who were not, however it was
not statistically different (p > 0.05).
Benzene exposure intensity in this research
was measured with OVM and SPMA. OVM is
an equipment to measure benzene external
dosage that is received by employees. SPMA
is benzene internal dosage that was measured
from the employee’s urine after being exposed
to benzene. The result of benzene intensity
measurement could be concluded well, if OVM
and SPMA measurement were performed
entirely to employees who were exposed to
benzene and to some employees who were not
exposed to benzene as a control. Then, the result
was analyzed and related to some blood
disorders occurrence.
In this research, OVM and SPMA
measurement was performed in the year 2007
and 2009. Sampling was performed randomly
in each location, however the number of sample
examined was relatively low compared to the
total employees that were exposed to benzene.
Therefore, the number of OVM and SPMA were
not sufficient to be analyzed and the relationship
between benzene exposure intensity with blood
count disorder could not be concluded. Some
toxicology causality principles, such as the
absence of the causal relationship between the
dosage amount and disorder level, and the level
of relationship strength between cause and effect,
also could not be concluded in this research.
The research subjects of OVM and SPMA
in the year 2007 were 117 employees. Research
subjects had an average age of 29.38 ± 8.43
years. Working term of the employees was
various, between 1 to 32 years. SPMA degree
in urine was various from 0.8 to 47 ìg/g
creatinine, although the average was normal, i.e.
11.54 ± 5.28 ìg/g creatinine. Benzene degree
from OVM was varied from 0.1 to 52.3 ppm,
the average was above normal, i.e. 1.07 ± 5.5
ppm. The average of BMI was in normal
category, i.e. 23.38 ± 3.10. Some of the smoking
employees, with the number of cigarette
consumed varied from 1 to 20 cigarettes per
day. Complete description of base
characteristic proportion was described in
TABLE 1.
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The research subjects of OVM and SPMA
were 52 employees. The average age of the
research subjects was 25.62 ± 6.51 years.
SPMA degree in urine was various from 12 to
412 ìg/g creatinine, the average was above
normal, i.e. 55.90 ± 43.6 ìg/g creatinine.
Benzene degree from OVM was various from
0.1 to 59.5 ppm, the average was above normal,
i.e. 4.153 ± 13.600 ppm. BMI average was in a
normal category, i.e. 22.39 ± 3.52. The average
of benzene exposed duration was 111.98 ±
120.00 minutes, the fastest was 3 minutes and
the longest was 480 minutes. The complete
description of base characteristic proportion
was showed in TABLE 2.
TABLE 1. Proportion of subject base characteristic for OVM (organic vapour monitor) and SPMA (S-
phenylmercapturic acid) in 200710
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TABLE 2. Proportion of subject base characteristic for OVM (Organic Vapour Monitor) and SPMA (S-
phenylmercapturic acid) in 200910
Some complete blood count revealed blood
disorders such as anemia, thrombocytopenia,
leucopenia, and erythropenia. Bivariate analysis
was performed to analyze the relationship
between benzene degree (OVM and SPMA)
with the blood disorders. Due to the insufficient
number of OVM and SPMA samples, the
relationship between benzene exposure intensity
and the disorders of blood count could not be
concluded.
Relationship between the high degree of
SPMA and OVM, with the occurrence of
leucopenia, anemia, and thrombocytopenia was
not statistically different (p > 0.05). Risk of
leucopenia, anemia, and thrombocytopenia in
the group with high SPMA and OVM compared
to the low group still could not be concluded
due to insufficient the number of samples in
leucopenia, anemia, and thrombocyto-penia
case with high OVM and SPMA.
Five erythropenia cases in the research
subject were observed in this study. The
relationship between the high SPMA degree,
with the occurrence of erythropenia was not
statistically significant (p > 0.05). Erythropenia
risk in the group with high SPMA compared to
the low group cannot be concluded due to
insufficient number of sample in erythropenia
case with high SPMA degree. Erythropenia risk
in the group with high OVM was 2.30 (95%CI:
0.24-22.40) times than the low OVM, however
it was not different statistically (p > 0.05).
The number of OVM and SPMA were not
sufficient, thus the relationship between the
intensity of benzene exposure intensity and the
blood disorders could not be concluded. One
anemia case and erythropenia of research
subjects were observed in this study.
Relationship between the high degree of SPMA
and OVM with the occurrence of anemia and
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erythropenia was not statistically significant (p
> 0.05). The risk of anemia and erythropenia in
the high SPMA and OVM group compared to
the low group could not be concluded due to
the insufficient number of samples.
Benzene exposure can cause degradation
of one of complete blood count result, such as
erythropenia, leucopenia, anemia, or thrombo-
cytopenia. Moreover, it can also cause bicyto-
penia, pancyto-penia, or disorders or peripheral
blood morphology. In this research, the
degradation of one of peripheral blood
morphology tended to increase during 3 years
obsevartion consecutively. However, the
complete blood count value was still in a normal
range. The tendency of degradation of one of
peripheral blood morphology was analyzed for
3 years in succession, although it was still in a
normal range. This aims to keep the guard on
the decrease of complete blood count to below
the normal limit, even bicytopenia or
pancytopenia.
Intensity of benzene exposure in this
research was measured with OVM (external
dosage) and SPMA (internal dosage). The result
of the benzene intensity measurement could be
concluded well, if the measurement OVM and
SPMA was performed entirely to the employees
who were exposed to benzene and to some
employees who were not exposed to benzene
as a comparison. In this research, the measure-
ment of OVM and SPMA was performed in
2007 and 2009. Sampling was performed
randomly in each location, although the number
of sample checked was still small compared to
the total employees who were exposed to
benzene.The number ofOVM andSPMA sample
was not sufficient, so the relationship between
the benzene intensity with blood count disorders
still could not be concluded. Some toxicology
causality principles, such as the absence of
cause-effect relationship, dosage response
relationship, temporality, level of disorders
impacted, level of relationship strength between
cause and effect, could not be concluded in this
research.
The occurrence of blood count degradation,
like anemia (20.6%), leucopenia (1.6%),
thrombo-cytopenia (4.3%), erythropenia
(15.9%), bicytopenia (0.1-0.3%) also happen-
ed, although for 1 year only, the number was
few and insignificant. Bivariate analysis pointed
out that the relationship between benzene
exposure and the appearance of erythropenia,
thrombocytopenia, leucopenia, and anemia was
not statistically significant (p > 0.05). It means
that chronic benzene exposure in the production
process in an oil and natural gas company in
East Kalimantan, has not caused the number
degradation of erythrocyte, leukocyte, platelet,
and haemoglobin. Bivariate analysis analyzed
that the relationship between benzene exposure
and the appearance of bicytopenia could not be
concluded, because the sample number in
bicytopenia case was not sufficient. Employees
that were exposed to benzene had risk to have
degradation of one of complete blood count for
3 years in succession (still in a normal range)
was 1.71 times higher (95% CI: 1.18 – 2.48)
compared to those who were not exposed to
benzene (p < 0.05).
DISCUSSION
This research result is in accordance to
Collins et al.12 research, where there were not
any differences of the blood cell number
between two groups of employees who were
exposed to benzene 0.01-0.04 ppm and the
employees who were not exposed to benzene.
According to WHO13, a study result shows that
chronic benzene exposure 0.009-1.4 ppm does
not cause the occurrence of blood count result
degradation.
The opposite result was shown by
Tusmiyati’s research which reported that
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employees in a company in Semarang with
benzene degree in the air of the work place was
around 7-17 ppm with average duration of work
8.25 years.14 Therefore, there was degradation
of erythrocyte number without leukocyte and
platelet number degradation. Lan et al.15 showed
that employees of shoes factory in China who
were exposed to benzene <1 ppm had lower
leukocyte and substantial platelet number
compared to control group.
Askoy16 reported that there was pan-
cytopenia and leukaemia case of factory’s
workers in Turkey as the result of benzene
exposure 150-210 ppm and sometimes reaching
650 ppm, after working for 2-35 years. Rothman
et al.17 showed that there was degradation of
erythrocyte, leukocyte, platelet, and hemoglobin
to benzene exposed workers in China with the
exposure level 1-328 ppm.
Further explanation to employees that
experience degradation of erythrocyte, leuko-
cyte, platelet, bicytopenia, even pancytopenia
as a result of low concentration of benzene
chronic exposure (<1 ppm), shows certain
genotype varieties, i.e. polimorphism enzim
myeloperoksidase (MPO-463GG), NAD(P)H
quinone oxidoreductase (NQO1-465CT),
CYP2E1, GSTM1, and GSTT1.15 The genotype
variety causes someone to be more vulnerable
to have benzene toxication, although being
exposed to benzene with low concentration
(<1ppm). In this research, genotype variety
check up of MPO-463GG, CYP2E1, GSTM1,
GSTT1 and NQO1-465CT was not conducted.
For this reason, it could not be explained
whether the absence of degradation of blood
count result to chronic benzene exposed
employees, was caused by the absence of gen
variants.
Another factor that can affect the appearance
of disorders as the result of benzene exposure
is the high benzene exposure concentration. The
higher the benzene exposure dosage, the higher
the possibility of the disorder appearance is.
Next factor is exposure period. The longer the
benzene exposure, the higher the possibility of
disorder appearance is—the period is very
various, from 5 to 25 years. Less K3 application
also affects the problem. The example of less
K3 application is because the company still
underestimates the danger of benzene, there is
not any policy about benzene, and employees
do not wear breath protector equipment
properly.13,17
In this research, the measurement of OVM
and SPMA was performed randomly in 2007
and 2009. Sampling was done randomly in each
location, but the sample number checked was
still small compared to the total employees who
were exposed to benzene. The sample number
of OVM and SPMA was not sufficient to be
analyzed. The complete blood count of subjects
that was checked by OVM and SPMA was
certainly not conducted completely. The
following discussion describes OVM and
SPMA exclusively, and is not related to
research subject in peripheral complete blood
count that is discussed in another chapter.
Therefore, the relationship between benzene
intensity with blood count disorder still could
not be concluded.
Value limit for benzene according to
ACGIH8 is 0.5 ppm (1.6 mg / m3) for working
in average for 8 hours a day and 40 hours a
week. Indonesian government decides NAB
Benzene is 10 part per million (ppm) according
to Letter Release from the Minister of Labors
dan Transportaton and Cooperative Nomot SE
01/Men/1997 about the number of value limit
of chemical substances. Australia, Denmark,
Finlandia, Japan and Netherland tend to
decrease NAB benzene from 10 ppm to 1 ppm.
This research uses NAB 1 ppm standard.
OVM benzene degree 2007 was various
from 0.1 to 52.3 ppm. The average was more
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than normal, i.e. 1.07±5.5 ppm, while the
proportion of abnormal OVM value was 12
(10.3%) people. Benzene degree from OVM
2009 was various from 0.1 to 59.5 ppm,
whereasthe average was more than normal, i.e.
4.153+13.6 ppm. The proportion of abnormal
OVM was 5 (9.6%). The measurement was
performed once only in the year 2007 and 2009.
The measurement in year 2007 and 2009
showed that the average of benzene degree was
above NAB, which had possibility to cause bad
effect to the employees.
Some other researches show different
degree in every measurement. Based on Collins
et al.12 research, workers were exposed to
benzene in the range 0.01-1.4 ppm compared
those who were not exposed. Research by Lan
et al.15 showed that shoes factory workers in
China were exposed to benzene <1 ppm.
Tusmiyati14 reported that workers in Semarang
worked with benzene degree in the air of work
area was around 7-17 ppm.13 Aksoy16 reported
that there was benzene exposure 150-2210 ppm
and sometimes reaching 650 ppm after working
for 2-35 years. This variety of benzene degree
depends on several things, like the type of job,
the kind of benzene source in the work field,
the kind of measurement equipment, the
measurement method, etc.
SPMA degree in urine sample which was
taken in the end of working hour can be an
indicator of reliable benzene exposure for one
shift working with exposure concentrate
reaching 0.1 ppm.18-21Biological exposure limit
that is allowed or Biological Exposure Indices
(BEI) for benzene using biomarker SPMA in
urine in the end of working shift for 8 hours
working period was 25 mg /g creatinine.
SPMA degree of 2007 in urine was various
from 0.8 to 47 ìg/g creatinine, although the
average was normal, i.e. 11.54+5.28 ìg/g
creatinine. Proportion of abnormal SPMA value
in 2007 was 5 (4.5%). In contrast, SPMA value
in 2009 in urine was various from 12 to 412 ìg/
g creatinine, while the average was more than
normal, i.e. 55.90±43.6 ìg/g creatinine, with
abnormal value of 40 (76.9%).
Proper K3 application enables the number
of benzene that enter the workers’ body in a
safe level, which can be proved from the result
of normal urine SPMA measurement in 2007.21
Although chronic benzene exposure in the
company is beyond NAB, benzene that could
enter the body was not much (under normal
level), especially because proper breath
protector usage (respirator), thus it did not
cause blood count degradation in the workers
who were exposed to benzene in the oil and
natural gas company in East Kalimantan.
Respirator that could be used by employees in
the company was half mask or full mask which
was equipped cartridge as chemical fume
absorber. Besides, there was a warning board
about the danger of benzene, toluene, xilene
which was placed around benzene, toluene, and
xilene sources.
In 2009, urine SPMA average was more
than normal, although K3 had been highly
socialized in the company. According to
ACGIH8, the case can happen because of some
factors, such as: self protector usage, factor in
a work area, benzene exposure outside the
working area, and research factor method.
Although the company had highly socialized
benzene program and proper self protective
equipment usage, maybe there were some
employees who did not know or did not obey
the rule. Factors in the workplace can also take
effect, for example: the working period, benzene
exposure through skin, the existence of another
chemical substance, temperature and air
humidity. Another factor is benzene exposure
outside the working area, for example: air
polution, cigarrette smoke, food and beverage.
Most employees were smokers, and it can
increase benzene degree in the blood.
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Measurementmethodfactor,suchas:contaminated
sample when storing, sample delivery to
laboratorium, and placement of sampling
equipment in breath zone can also affect it.
CONCLUSION
This research showed that employees who
are exposed to benzene have risk of degrada-
tion of either hemoglobin, erythrocyte, platelet,
or leukocyte 1.71 times higher compared to those
who are not exposed to benzene, however it is
still in normal range and not statistically sig-
nificant. Moreover relationship between ben-
zene exposure intensity and the low blood count
result has not been found.
Some advices that can be given are that the
complete blood count check up and OVM, and
SPMA need to be performed to all employees
who are exposed to benzene. In addition, entire
socialization about benzene program to
employees needs to be conducted, as well.
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